We previously provided evidence for an NKG2D-mediated surveillance of primary tumours using two independent mouse models: the EμMyc transgenic mouse developing B-cell lymphoma and the transgenic TRAMP mouse as a model of prostate cancer3, 4. The gene discussed is KLRK1; the disease is B-cell non-Hodgkin lymphoma.